Background -Recent animal studies have suggested that changes in oxygen tension may alter airway responses to bronchoconstrictor and bronchodilator stimuli. These effects may have relevance to the management of acute exacerbations of asthma but have not been well studied in man. This study was designed therefore to examine the effect of acute hyperoxia (Fio2 1.0) on the bronchodilator response to salbutamol in stable asthmatic patients. Methods -Twelve stable adult asthmatic patients (three women) were studied using a randomised double blind placebo controlled crossover design. On two study days following baseline measurements patients breathed either air (Fio2 0.21) or oxygen (Fio2 1.0) for 10 minutes alone and then in combination with three incremental doses ofnebulised salbutamol administered at 15 minute intervals. The same protocol was employed on two further study days using nebulised saline instead of salbutamol. Results -The mean absolute change in forced expiratory volume in one second (FEV1) from baseline after salbutamol was similar on the normoxic and hyperoxic study days but significantly greater than the study days on which nebulised saline was administered. Conclusion -Acute hyperoxia does not potentiate the immediate bronchodilator response to salbutamol in stable asthmatic patients. (Thorax 1996;51:853-854) Keywords: hyperoxia, salbutamol, asthma.
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tions of asthma may not only improve gas exchange, but could also enhance the effect of bronchodilators. The present study was designed to examine the effect of acute hyperoxia on the bronchodilator response to salbutamol in patients with asthma.
Methods
Twelve adult asthmatic patients (three women) with a mean (SD) age of 47 (14) years and forced expiratory volume in one second (FEVI) of 2.05 (0.6) litres (79 (17)% predicted) were recruited into the study. On four study days after 30 minutes of supine rest patients were commenced on a closed breathing circuit. Following a 10 minute run-in period during which patients breathed air (Fio2 0.21), baseline measurements of FEV1, oxygen saturation (Sao2%), respiratory rate, heart rate, and inspired and expired oxygen and carbon dioxide levels (%) were made. Venous blood was also taken for assay of plasma catecholamines. Patients were then randomised to receive either air (Fio2 0.21) on two study days or oxygen (Fio2 1.0) on the remaining two study days. The gases were administered in a randomised double blind fashion. Following a further 10 minutes breathing the study gas through the closed breathing circuit, the patients received either three incremental concentrations of nebulised salbutamol (0.05 mg/ml, 0.17 mg/ml, 5 mg/ml) or placebo (normal saline) at 15 minute intervals, again in a double blind fashion. Baseline measurements were repeated 13 minutes after each nebulisation until completion of the study day. All patients gave written informed consent to the study and the protocol was approved by the West ethics committee. 
Results
There were no significant differences in baseline measurements between the study days (table 1). The mean absolute change in FEV1 from baseline after salbutamol was similar on both the normoxic and hyperoxic study days but significantly greater (p < 0.01) than the study days in which nebulised saline was 
